Hospitalizations, hospitalization rates, mortality rates, in-hospital mortality, US trends, age-specific trends, hospitalizations by age group, age categories, 65 years or older, ≥65 years, 18-64 years, 35-44 years, 45-54 years, 55-64 years, 65-74 years, ≥75 years, 75 years or older, epidemiology, HF subtype, EF group, EF phenotypes, reduced ejection fraction, HFrEF, preserved ejection fraction, HFpEF, Nationwide Inpatient Sample, NIS
death rates, mortality rates, age-adjusted mortality rate, AAMR, all-cause mortality rates, US trends, death rates by race, racial differences, American Indian, Alaska Native, Asian, Hawaiian, Pacific Islander, Black, African American, White, Hispanic, Non-hispanic, multi-ethnic, CDC WONDER, CDC statistics
death rates, mortality rates, age-adjusted mortality rate, AAMR, absolute deaths, stratified by sex, death rates by sex, sex differences, males vs females, stratified by sex, age-adjusted deaths by sex, all-cause deaths, cardiovascular deaths, CDC WONDER, CDC statistics
Prevalence, prevalence rates, worldwide prevalence, global prevalence, global trends, epidemiology, HF subtype, EF group, EF phenotypes, reduced ejection fraction, HFrEF, mildly reduced ejection fraction, HFmrEF, preserved ejection fraction, HFpEF, cohort studies, ESC registry, Europe, European Society of Cardiology, G-CHF registry, Global Congestive Heart Failure registry, ASIAN-HF registry, Asian Cardiac Death registry, Japan, INTER-CHF study, International congestive HF study, african countries, Africa, China, Australia, Haiti
Prevalence, prevalence in the US, NHANES data, Medicare beneficiaries, ARIC study, atherosclerosis risk in communities study, incidence according to race/ethnicity, racial differences, incidence according to sex, males vs females, sex differences, US, United States
Incidence, incidence in the US, cohort studies, Olmstead County, Medicare beneficiaries, Framingham study, FHS, atherosclerosis risk in communities study, ARIC study, cardiovascular health study, CHS, American Indians, Alaskan natives, older adults, age 55 years or older, ≥55 years, HF subtypes, incidence according to EF group, EF phenotype, reduced ejection fraction, HFrEF, preserved ejection fraction, HFpEF, incidence according to race/ethnicity, incidence according to sex, sex differences, racial differences, US, United States
Incidence, Lifetime risk, cohort studies, Framingham study, FHS, Chicago Heart Association, CHA, atherosclerosis risk in communities study, ARIC study, cardiovascular health study, CHS, risk according to EF group, EF phenotype, reduced ejection fraction, HFrEF, preserved ejection fraction, HFpEF, risk according to race/ethnicity, risk according to sex, sex differences, racial differences
current treatments, advanced HF therapies, heart transplant, dual organ transplants, transplant volumes, US trends, heart-kidney, heart-liver, heart-lung, US, United States
current treatments, advanced HF therapies, heart transplant, LVAD, left ventricular assist devices, US trends, heart transplant data, US, United States
Hospitalizations, hospitalization rates, epidemiology, trends in hospitalizations, HF subtype, EF group, EF phenotypes, hospitalizations by EF group, reduced ejection fraction, HFrEF, mildly reduced ejection fraction, HFmrEF, preserved ejection fraction, HFpEF, incidence curves
